KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.433 7 days ( -4.63 % )
Last Price $4.29 -1.72 %
High/ Low $4.29 - $4.42 8.65%
Chg 7 Days 3.62 % $4.14 $4.29
Chg 30 Days -1.04 % $4.34 $4.29
Chg 12 mos 406.25 % $0.85 $4.29
Trend - 3 mos 5.86 % Width: 33.36 %
Trend - 12 mos 15.15 % Width: 360.22 %
Pred. range - 3 mos $4.03 - $5.38 -5.95 % - 25.44 %
Pred. range - 12 mos $2.44 - $11.24 -43.09 % - 161.89 %
Short MA avg 3 mos Buy Apr 22, 2024 - 5 days
Long MA avg 3 mos Buy Apr 22, 2024 - 5 days
Short/Long MA avg 3 mos Sell Apr 18, 2024 - 7 days
Short MA avg 12 mos Sell Apr 11, 2024 - 12 days
Long MA avg 12 mos Sell Apr 25, 2024 - 2 days
Short/Long MA avg 12 mos Buy Jan 02, 2024 - 81 days
Pivot Short Sell Apr 18, 2024 - 7 days
Bollinger Buy Apr 18, 2024 - 7 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Marker Therapeutics Inc.

Marker Therapeutics. Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill... MRKR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT